Integra LifeSciences Holdings (IART) 2003年年度报告「NASDAQ」.pdf

《Integra LifeSciences Holdings (IART) 2003年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Integra LifeSciences Holdings (IART) 2003年年度报告「NASDAQ」.pdf（92页珍藏版）》请在三个皮匠报告上搜索。

1、 Annual ReportCorporate OfficersStuart M.EssigPresident,Chief Executive Officer andDirectorGerard S.CarlozziExecutive Vice President,Chief OperatingOfficerJohn B.Henneman,IIIExecutive Vice President,ChiefAdministrative Officer and SecretaryDavid B.HoltzSenior Vice President,Finance andTreasurerDonal

2、d R.NocioloSenior Vice President,OperationsJudith E.OGrady,R.N.,M.S.N.,R.A.C.Senior Vice President,Regulatory,QualityAssurance and Clinical AffairsRobert D.PaltridgeSenior Vice President,Global SalesDeborah A.LeonettiVice President,Global MarketingOutside DirectorsRichard E.Caruso,PhD.(3)Chairman of

3、 the Board of DirectorsDavid C.Auth(1)Former Chief Executive Officer andFounder of Heart Technology,Inc.Keith Bradley,Ph.D.(1)(2)(3)Former Professor of InternationalManagement and Management Strategyat the Open University and City University,London Business SchoolsNeal Moszkowski(1)(2)Managing Direc

4、tor of Soros FundManagement LLC and Co-Chief Executiveof Soros Private EquityJames M.Sullivan(2)(3)Executive Vice President of LodgingDevelopment,Marriott International,Inc.(1)Compensation Committee member(2)Audit Committee member(3)Nominating Committee memberOUR VISION:Integra is a market leading,i

5、nnovative medical device company focused on helping themedical professional enhance the standard of care.OUR MISSION:Integra seeks to provide customers with clinically relevant,innovative and cost-effectiveproducts that improve the quality of life.Presidents MessageTo Our Stockholders:In 2003,we ach

6、ieved record revenues and operating income while continuing to develop our extensive productofferings and global infrastructure.We grew total revenues to$185.6 million in 2003,a 58%increase over 2002.Operating income was$39.6 million in 2003,a 107%increase over 2002.Net income totaled$26.9 millionin